Xiong Xiaolu, Jiao Jun, Gregory Anthony E, Wang Pengcheng, Bi Yujing, Wang Xiaoyi, Jiang Yongqiang, Wen Bohai, Portnoy Daniel A, Samuel James E, Chen Chen
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology.
Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Bryan.
J Infect Dis. 2017 May 15;215(10):1580-1589. doi: 10.1093/infdis/jiw470.
Coxiella burnetii is a gram-negative bacterium that causes acute and chronic Q fever. Because of the severe adverse effect of whole-cell vaccination, identification of immunodominant antigens of C. burnetii has become a major focus of Q fever vaccine development. We hypothesized that secreted C. burnetii type IV secretion system (T4SS) effectors may represent a major class of CD8+ T-cell antigens, owing to their cytosolic localization. Twenty-nine peptides were identified that elicited robust CD8+ T-cell interferon γ (IFN-γ) recall responses from mice infected with C. burnetii. Interestingly, 22 of 29 epitopes were derived from 17 T4SS-related proteins, none of which were identified as immunodominant antigens by using previous antibody-guided approaches. These epitopes were expressed in an attenuated Listeria monocytogenes vaccine strain. Immunization with recombinant L. monocytogenes vaccines induced a robust CD8+ T-cell response and conferred measurable protection against C. burnetii infection in mice. These data suggested that T4SS effectors represent an important class of C. burnetii antigens that can induce CD8+ T-cell responses. We also showed that attenuated L. monocytogenes vaccine vectors are an efficient antigen-delivery platform that can be used to induce robust protective CD8+ T-cell immune responses against C. burnetii infection.
伯氏考克斯氏体是一种革兰氏阴性细菌,可引起急性和慢性Q热。由于全细胞疫苗的严重不良反应,鉴定伯氏考克斯氏体的免疫显性抗原已成为Q热疫苗开发的主要焦点。我们推测,由于其胞质定位,伯氏考克斯氏体IV型分泌系统(T4SS)效应蛋白可能代表一类主要的CD8 + T细胞抗原。鉴定出29种肽,它们能从小鼠感染伯氏考克斯氏体后引发强烈的CD8 + T细胞干扰素γ(IFN-γ)回忆反应。有趣的是,29个表位中的22个来自17种与T4SS相关的蛋白,使用先前的抗体引导方法均未将其鉴定为免疫显性抗原。这些表位在减毒的单核细胞增生李斯特菌疫苗株中表达。用重组单核细胞增生李斯特菌疫苗免疫可诱导强烈的CD8 + T细胞反应,并为小鼠提供可测量的抗伯氏考克斯氏体感染保护。这些数据表明,T4SS效应蛋白代表伯氏考克斯氏体的一类重要抗原,可诱导CD8 + T细胞反应。我们还表明,减毒的单核细胞增生李斯特菌疫苗载体是一种有效的抗原递送平台,可用于诱导针对伯氏考克斯氏体感染的强大保护性CD8 + T细胞免疫反应。